Mitchell Mcleod Pugh & Williams Inc Amarin Corp Plcuk Transaction History

Mitchell Mcleod Pugh & Williams Inc

  • $476 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
SELL
$1.13 - $3.69 $12,723 - $41,549
-11,260 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$3.24 - $5.18 $18,529 - $29,624
-5,719 Reduced 33.68%
11,260 $38,000
Q2 2020

Jul 17, 2020
BUY
$4.78 - $8.26 $27,336 - $47,238
5,719 Added 50.79%
16,979 $117,000
Q1 2020

Apr 08, 2020
BUY
$4.0 - $21.53 $45,040 - $242,427
11,260 New
11,260 $45,000

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email